NasdaqGS - Nasdaq Real Time Price USD
HUTCHMED (China) Limited (HCM)
17.72
+0.57
+(3.32%)
At close: June 12 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 4 | 5 |
| Avg. Estimate | 0 | 0 | 0.64 | 0.5 |
| Low Estimate | 0 | 0 | -0.02 | 0.09 |
| High Estimate | 0 | 0 | 2.04 | 1.11 |
| Year Ago EPS | -- | -- | 0.22 | 0.64 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 23 | 25 |
| Avg. Estimate | -- | -- | 693.4M | 833.64M |
| Low Estimate | -- | -- | 568.49M | 590M |
| High Estimate | -- | -- | 800.9M | 1.03B |
| Year Ago Sales | -- | -- | 630.2M | 693.4M |
| Sales Growth (year/est) | -- | -- | 10.03% | 20.23% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.64 | 0.5 |
| 7 Days Ago | 0 | 0 | 0.17 | 0.5 |
| 30 Days Ago | 0 | 0 | 0.17 | 0.5 |
| 60 Days Ago | 0 | 0 | 0.17 | 0.5 |
| 90 Days Ago | 0 | 0 | 0.47 | 0.39 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 2 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HCM | -- | -- | 191.48% | -22.69% |
| S&P 500 | 13.13% | 2.45% | 7.55% | 14.06% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Neutral to Neutral | 8/1/2024 |
| Upgrade | Deutsche Bank: Hold to Buy | 11/24/2023 |
| Maintains | Goldman Sachs: Neutral to Neutral | 11/10/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/5/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 7/24/2023 |
| Maintains | Goldman Sachs: Neutral | 8/9/2022 |
Related Tickers
PRGO Perrigo Company plc
27.25
-0.44%
CPIX Cumberland Pharmaceuticals Inc.
5.86
+3.35%
RDY Dr. Reddy's Laboratories Limited
16.17
+1.51%
ANIK Anika Therapeutics, Inc.
11.27
-0.35%
AMRX Amneal Pharmaceuticals, Inc.
7.96
+2.31%
HLN Haleon plc
11.01
+0.92%
PBH Prestige Consumer Healthcare Inc.
85.14
+0.02%
ALVO Alvotech
9.84
-2.67%
BHC Bausch Health Companies Inc.
5.51
+3.38%
AVDL Avadel Pharmaceuticals plc
9.34
-5.56%